|
Newsbrief:
AMT,
Foxy
Methoxy
Permanently
Placed
on
Schedule
I
10/15/04
https://stopthedrugwar.org/chronicle-old/358/scheduleI.shtml
With a notice in the Federal
Register on September 29, the DEA issued a "final rule" placing the psychedelic
typtamines Alpha-Methyltryptamine (AMT) and 5-Methoxy-N,N-Diisopropyltryptamine
(Foxy Methoxy) in Schedule I of the Controlled Substances Act. It
has been illegal to buy, sell, or possess either substance without a DEA
license since April 2003, when the agency temporary placed them on Schedule
I. The final rule makes permanent the temporary scheduling that took
effect last year.
Typically, substances may
be temporarily scheduled for no more than one year, but in March 2004,
the DEA published a notice that proceedings to permanently schedule AMT
and Foxy Moxy were underway, thus gaining another six months to do so.
That six-month grace period expired two days after the DEA's latest Federal
Register notice.
Under the Controlled Substances
Act, substances may be classified as Schedule I only if the meet three
criteria: that they have a high potential for abuse, no currently accepted
medical use in treatment in the United States and are not safe for use
under medical supervision. According to the DEA, AMT and Foxy Methoxy
meet those criteria. (Never mind for now that the DEA also says that
marijuana meets those criteria.)
AMT and Foxy Methoxy share
their mind-warping properties with other tryptamines, including DMT and
psilocybin. The tryptamines were explored by chemist Sasha Shulgin,
who first synthesized Foxy Methoxy in 1981, and who is cited in the DEA's
final rule. According to the DEA, AMT has subjective effects similar
to amphetamines and MDMA (Ecstasy), while Foxy Methoxy's effects are more
akin to those experienced with LSD.
The designer drugs came to
the attention of federal regulators in the 1990s, when they began appearing
as an adjunct to Ecstasy and other drugs in the European rave scene.
In the past several years, the DEA reported, the psychedelic pair crossed
the Atlantic, exciting the agency's worry. DEA described the use
of AMT and Foxy Methoxy as an "emerging problem" at raves and clubs in
Arizona, California, Florida, and New York. AMT and Foxy Methoxy
may be an emerging problem, but not a very big one, according to the DEA's
own statistics. The agency has filed only 14 AMT cases since 1999
and 32 Foxy Methoxy cases.
With psychedelics such as
AMT and Foxy Methoxy, warns the DEA, "the alteration of sensory perception
and judgment can pose serious health risks to the user and the general
public." And to consensus reality. Find out more about AMT
and Foxy Methoxy at the Vault of Erowid's respective web pages for each
substance, http://www.erowid.org/chemicals/amt/amt.shtml
and http://www.erowid.org/chemicals/5meo_dipt/5meo_dipt.shtml
online.
-- END --
|
Issue #358, 10/15/04
A Message from the Executive Director on What DRCNet is Planning After Election Day and Why We Need Your Help |
Now You See It, Now You Don't: The Amazing Vanishing DEA Pain FAQ |
Montana Medical Marijuana Initiative Appears Headed for Victory |
Second Medical Marijuana Initiative Faces Tough Fight in Oregon |
Medical Marijuana on the Local Ballot in Ann Arbor, Berkeley, Columbia |
DRCNet Book Review: "Narcotic Culture: A History of Drugs in China" by Frank Dikotter, Lars Laaman and Zhou Xun (Oxford University Press, $35.00 HB) and "Opium: A Portrait of the Heavenly Demon" by Barbara Hodgson (Greystone Press, $14.95 PB) |
Newsbrief: VP Hopeful John Edwards Makes Methamphetamine a Campaign Issue |
Newsbrief: AMT, Foxy Methoxy Permanently Placed on Schedule I |
Newsbrief: Congress Votes to Double US Troops in Colombia |
Newsbrief: European Drug Think Tank Rips US on Afghan Opium Policy -- No "Plan Afghanistan," Please, Says Senlis Council |
Newsbrief: Dinosaurs Walk the Earth as Prohibition Party, Independent Candidate Demand Return of Alcohol Prohibition |
Newsbrief: This Week's Corrupt Cops Stories |
This Week in History |
Administrative Assistant: Part-Time Job Opportunity at DRCNet |
The Reformer's Calendar
|
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
|
PERMISSION to reprint or
redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby
granted. We ask that any use of these materials include proper credit and,
where appropriate, a link to one or more of our web sites. If your
publication customarily pays for publication, DRCNet requests checks
payable to the organization. If your publication does not pay for
materials, you are free to use the materials gratis. In all cases, we
request notification for our records, including physical copies where
material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network,
P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202)
293-8344 (fax), e-mail [email protected]. Thank
you.
Articles of a purely
educational nature in Drug War Chronicle appear courtesy of the DRCNet
Foundation, unless otherwise noted.
|
